Clinical Trials Browser

Phase 4 × INDUSTRY × Adenomatous Polyposis Coli × Clear all

NCT00140894 2019-09-20

A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Phase 4 Terminated

Gastrointestinal

Cancer Pain, Osteoarthritis, Adenomatous Polyposis Coli